Studying the mechanisms by which pathogens evade the immune response may lead to new therapeutic strategies (pages 939–944).
This is a preview of subscription content, log in via an institution to check access.
References
Sharipo, A., Imreh, M., Leochiks, A., Imreh, S. & Masucci, M.G. A minimal Gly-Ala repeat prevents the interaction of ubiquinated IκBα with the proteasome: A new mechanism for selective inhibition of proteolysis. Nature Med. 4, 939–944 (1998).
Coux, O., Tanaka, K. & Goldberg, A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 265, 801–847 (1996).
Masucci, M.G. & Ernberg, I. Adaptation to a life within the immune system. Trends Microbiol. 2, 125–130 (1994).
Steven, N.M. Epstein-Barr virus latent infection in vivo. Rev. Med. Virol. 7, 97–106 (1997).
Levitskaya, J. et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375, 685–688 (1995).
Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A. & Masucci, M.G. Inhibition of ubiquitin/protea-some-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA 94, 12616–12621 (1997).
Barnes, P.J. & Karin, M. Nuclear factor κB—a pivotal transcription factor in chronic inflammatory disease. New. Eng. J. Med. 336, 1066–1071 (1997).
Bach, F.H. et al. Modification of vascular responses in xenotransplantation: Inflammation and apoptosis. Nature Med. 3, 944–948 (1997).
Beg, A.A. & Baltimore, D. An essential role for NF-kappa B in preventing TNF-alpha-induced cell death. Science 274, 782–784 (1996).
Wang, C.Y., Mayo, M.W. & Baldwin, A.S., Jr. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappa B. Science 274, 784–787 (1996).
Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. & Verma, I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappa B. Science 274, 787–789 (1996).
Riddell, S.R. & Greenberg, P.D. T cell therapy of human CMV and EBV infection in immunocompro-mised hosts. Rev. Med. Virol. 7, 181–192 (1997).
Karre, K. & Welsh, R.M. Viral decoy vetoes killer cell. Nature 386, 446–447 (1997).
Wiertz, E.J., Mukherjee, S. & Ploegh, H.L. Viruses use stealth technology to escape from the host immune system. Mol. Med. Today 3, 116–123 (1997).
Oldstone, M.B. How viruses escape from cytotoxic T lymphocytes: Molecular parameters and players. Virology 234, 179–185 (1997).
McMichael, A. T cell responses and viral escape. Cell 93, 673–676 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Powis, S. Lessons from an age-old war. Nat Med 4, 887–888 (1998). https://doi.org/10.1038/nm0898-887
Issue Date:
DOI: https://doi.org/10.1038/nm0898-887
- Springer Nature America, Inc.